Recombinant Human IFN-gamma-ProtTech Inc.

      
  
     
Home > Product > Cytokines & Interferons
Recombinant Human IFN-gamma
Interferon-gamma is the only member of the type II IFN, also called the immune interferon. Interferon-gamma is known for its primary ability to regulate overall immune system. It also has weak antiviral and anti-proliferative activity.1 It is involve in the activation, growth and differentiation of macrophages, T-cells, B-cells and NK cells.2 Macrophage stimulation with IFN-gamma induces direct antimicrobial and antitumor mechanisms.
  • Name: Recombinant Human IFN-gamma
  • Synonyms: IFNG, immune interferon, macrophage-activating factor
  • Catalogue Number:PT-CF-hIFG-001
  • Application:FOR LABORATORY RESEARCH USE ONLY.
  • Price: 50ug $80 100ug $100 500ug $400
  • Number:
  • Concentration:0.5mg/ml
  • Store:Avoid repeated freeze-thaw cycles. 12 months at -20 C to -80 C. 1 month at 2 C to 8 C.

Sequence: QDPYVKEAEN LKKYFNAGHS DVADNGTLFL GILKNWKEES DRKIMQSQIV SFYFKLFKNF KDDQSIQKSV ETIKEDMNVK FFNSNKKKRD DFEKLTNYSV TDLNVQRKAI HELIQVMAEL SPAAKTGKRK RSQMLFRG

Acession #: P01579

 

Quality control: Verified by Mass Spectrometry analyses.


Product Source: IFNG was produced in E. Coli cells transformed with human IFNG gene. This product is sterile and does not contain any components of animal origin.


References:

  1. Schroder,      K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004). Interferon-γ: an      overview of signals, mechanisms and functions. Journal of leukocyte biology,75(2),      163-189.

  2. Romagnani,      S. (1997). the th1/th2 paradigm. Immunology      today18(6),      263-266.

 

Cat No.: PT-CF-hIFG-001
Product Name: Recombinant Human IFN-gamma
Type: Protein
Property:
Origin:
Source: E.coli
Application: FOR LABORATORY RESEARCH USE ONLY.
Formulation: Sterile filtered through a 0.2 micron filter in 50% glycerol, 10 mM Phosphate buffer at pH 7.4, 200
Purity: >95% by SDS-PAGE gel
Storage: Avoid repeated freeze-thaw cycles. 12 months at -20 C to -80 C. 1 month at 2 C to 8 C.
Limitation:
Note: